<h1>Prism Medico and Pharmacy Reports Zero Investor Complaints for Quarter Ended June 30, 2026</h1>
Prism Medico and Pharmacy Ltd has reported zero instances of investor complaints throughout the quarter ended June 30, 2026. The company's report details all complaint metrics for the period, indicating a clean record in relation to shareholder grievances during the three-month timeframe.
The comprehensive statement on investor complaints provides specific data regarding the status of complaints at various stages of the reporting period. This information outlines the zero balance across all categories for the quarter.
Investor Complaint Summary for Q1 FY2026:
| Status | Count |
|---|---|
| Pending at the beginning of the quarter | 0 |
| Received during the quarter | 0 |
| Disposed off during the quarter | 0 |
| Remaining unresolved at the end of the quarter | 0 |
Stock Price Movement
Prism Medico and Pharmacy Ltd is edging higher in morning trading, currently standing at ₹29.37, reflecting a strong 6.03% gain. The shares have seen volatility throughout the session, having traded between an intraday low of ₹27.05 and a high mark of ₹30.40.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.